Connect with us

Technology

Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation

Published

on

SHANGHAI, Feb. 17, 2025 /PRNewswire/ — Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare industry. As a global innovation-driven pharmaceutical and healthcare group, Fosun Pharma places great emphasis on the transformative potential of AI technology in the pharmaceutical and healthcare sectors. The company actively embraces AI technology, deploying it in areas such as drug research and development, medical imaging, and precision medicine through both independent research and external collaborations, thereby driving transformation and development in the pharmaceutical industry through technological advancements. At the same time, Fosun Pharma is accelerating the deeper application of AI technology in marketing, customer service, and smart office solutions, using AI to improve quality and efficiency while promoting enhanced corporate management effectiveness.

Self-developed PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected with Deepseek R1

As a pioneer in the AI transformation of the pharmaceutical industry, Fosun Pharma recently launched its self-developed PharmAID decision intelligence platform internally. This platform establishes a full lifecycle intelligent decision-making network covering innovative R&D scenarios. Deeply integrated with global leading large model technologies, the platform has taken the lead in connecting to with Deepseek R1. Based on the PharmAID decision intelligence platform, Fosun Pharma is accelerating the development of “drug commercial value-assisted decision-making” capabilities, broadening decision-making perspectives, and improving decision accuracy. The platform enhances drug R&D efficiency and accelerates the transformation of R&D achievements by integrating point prediction, conformational prediction, binding mechanism analysis, toxicology optimization, medical writing, and clinical information extraction. This initiative aims to lead innovation and transformation, and it is the first self-developed AI decision intelligence platform in pharmaceutical industry.

The PharmAID decision intelligence platform offers AI translation and AI medical writing/revision features, significantly improving information retrieval and writing efficiency under the support of AI technology. At present, the PharmAID decision intelligence platform has integrated multiple professional clinical information and pipeline data platforms around the world, increasing content generation accuracy in the pharmaceutical and healthcare field by 50% compared to general large models, with data updated at T+1, ensuring outstanding accuracy and timeliness. Moreover, Fosun Pharma applies AI technology to carry out intelligent training for sales personnel and further assists business scenarios, achieving “more precise” marketing. Through the deep empowerment of the PharmAID decision intelligence platform, Fosun Pharma is building its digital competitiveness, leading the entire pharmaceutical industry into a new era of AI-driven innovation.

AI Technology Empowers Innovative R&D and Accelerate Breakthroughs

Fosun Pharma actively promotes AI-driven innovation. As early as 2022, Fosun Pharma formed a strategic partnership with AI pharmaceutical company Insilico Medicine, combining strengths to embark on a new journey in global AI drug R&D. In January 2025, Henlius, a subsidiary of Fosun Pharma, entered into a strategic collaboration with DP Technology for AI-assisted drug R&D, aiming to integrate AI with physical modeling to jointly advance new drug development processes. This collaboration leverages DP Technology’s technical strength and project experience in the “AI for Science” field, combining expertise in drug discovery and AI computing to provide new insights for the development of biologics antibodies/ADCs and small molecule drugs targeting difficult-to-drug targets.

Building an “AI+X” Smart Healthcare Ecosystem

In medical devices sector, Fosun Aitrox, a subsidiary of Fosun Pharma, focuses on the medical AI field and is one of the few companies in China offering comprehensive AI medical service solutions across multiple departments including radiology, pathology, ultrasound, cardiology, respiratory, orthopedics, neurology, and thyroid and breast surgery. Fosun Aitrox delves into medical institutions and primary healthcare service scenarios, identifying real needs and enhancing service capabilities in core scenarios of tiered healthcare systems, including early screening, remote diagnosis, and precision medicine. Through the “AI+X” model, Fosun Aitrox collaborates deeply with top medical centers, promoting the transformation of scientific research achievements and the popularization of standardized medical systems, empowering the construction of smart diagnosis and treatment systems. Its three major AI-assisted diagnostic product lines—radiology imaging, pathology imaging, and ultrasound imaging—have been widely used clinically and have won multiple world championships in international competitions.

Fosun Aitrox’s AI medical imaging products can quickly and accurately analyze medical imaging data, providing doctors with diagnostic suggestions, helping them more efficiently identify lesions and assess conditions, thereby improving diagnostic accuracy and timeliness. The application of this technology not only enhances the quality and efficiency of medical services but also benefits patients in remote and resource-scarce areas, allowing them to access high-quality medical services locally. To date, Fosun Aitrox has expanded its presence to cover 70% of China, with operating businesses in over 20 provinces, establishing nearly 10 regional smart healthcare project models. The company has released and is developing more than 70 AI products.

Additionally, Fosun Pharma’s incubated company, JeDiCare, leverages its extensive experience in image navigation algorithm development and interventional consumable design, along with a global perspective, to innovatively introduce AR navigation technology into minimally invasive surgery. Its self-developed puncture surgery navigation device (AR navigation puncture positioning system) is currently under market application review. This product features proprietary “monocular vision augmented reality” technology, integrating computer vision monocular tracking and AR display technology, not only achieving precise positioning but also optimizing the positioning process. In the future, with the assistance of the AR navigation puncture positioning system, primary hospitals will also be able to perform precise thoracoscopic surgeries, bringing high-quality medical care to more patients.

Looking ahead, Fosun Pharma will continue to increase investment and exploration in AI, accelerating the construction of AI innovation across the entire industry chain through independent research and external collaborations, leading the AI transformation of the pharmaceutical industry, and contributing more wisdom and strength to the cause of human health.

***

About Fosun Pharma

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

Fosun Pharma is patient-centered and unmet clinical needs-oriented. Through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and industrial investment, the company continues to enrich its innovative product pipeline and focus on differentiated product R&D with high-tech barriers, to continuously enhance the value of its pipeline. Fosun Pharma’s innovative products focus on core therapeutic areas such as solid tumors, hematologic tumors and immunity inflammation. It also strengthens core technology platforms such as antibodies/ADC, cell therapy, and small molecules.

Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma adheres to the business philosophy of “Innovation for Good Health”, continues to promote innovative transformation, actively deploys internationalization, strengthens business focus by product lines, promotes integrated operations and efficiency improvement, and is dedicated to being the global leading integrator of pharmaceutical and healthcare innovation.

For more information, please visit our official website: www.fosunpharma.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fosun-pharmaceutical-deeply-embraces-ai-self-developed-pharmaid-decision-intelligence-platform-boosts-efficient-innovation-302377891.html

SOURCE Fosun Pharma

Continue Reading

Technology

Automated Drone Technology Further Transforms Polish Mountain Rescue Operations

Published

on

By

How Poland’s TOPR Team is Revolutionizing Mountain Rescues with Automated DJI Docks

SHENZHEN, China, Nov. 3, 2026 /PRNewswire/ — With its steep peaks, deep valleys, and harsh winter conditions, the Tatra Mountains present immense challenges for search and rescue operations. Powered by DJI Enterprise’s next-generation automated drone technology, TOPR (Tatrzańskie Ochotnicze Pogotowie Ratunkowe), Poland’s dedicated volunteer mountain rescue service, is actively transforming its emergency response in rugged regions.

Building on their successful integration of DJI Enterprise equipment like the DJI Dock 3, TOPR recently initiated a pilot program with the newly released DJI Dock 4. The concept is groundbreaking for alpine rescues: launching a drone from an automated rooftop dock before the ground rescue team has even left the base.

“Certain locations are completely inaccessible by car, bike, or even snowmobile during winter,” explains Marcin Józefowicz, a TOPR rescuer and Head of Cybertech. Traditionally, a full mountain deployment could take up to two hours just to assemble the team and reach the trailhead on foot. To overcome this critical bottleneck, TOPR is looking to the sky.

This early deployment means a drone can reach a reported accident site in minutes instead of hours. “Crucially, we can assess the situation before we begin a physical operation,” says Józefowicz. This rapid aerial reconnaissance allows duty officers to determine if a rescue is genuinely needed, how many volunteers to dispatch, and exactly what equipment is required.

Once on the scene, the DJI Matrice 5TD helps TOPR make contact with people on the ground. Rescuers can use its loudspeaker to give instructions and ask whether assistance is needed, with hikers responding through gestures. If they indicate that they do not need help, the team can continue searching elsewhere. In total darkness, advanced thermal fusion imaging provides operators with near-daylight clarity, allowing them to pinpoint hikers’ headlamps and read topographic details simultaneously.

To conquer the mountainous terrain that frequently blocks standard communication signals, TOPR’s trial creatively utilizes a network of DJI O4 video transmission ground stations. By placing relay stations on observation towers and distant peaks, the drone can seamlessly roam between them. “This infrastructure allows us to extend our flight range even into neighboring valleys,” Józefowicz notes.

With automated flight triggers and a dock capable of swapping batteries in just 25 seconds for continuous operations, TOPR is exploring the ultimate future of mountain rescue. Beyond active missions, the automated fleet is testing the waters for daily hazard reconnaissance and trail monitoring. For TOPR’s dedicated volunteers, this continuous innovation serves one ultimate goal: reaching the injured faster, safer, and more effectively in the unforgiving Tatras.

1 All data was measured using a production model in a controlled environment. Some features are only available when paired with specific DJI drones, and may not be available in certain regions and countries. For more information, please refer to our official website: https://enterprise.dji.com/dock-4

About DJI

Since 2006, DJI has led the world with civilian drone innovations that have empowered individuals to take flight for the first time, visionaries to turn their imagination into reality, and professionals to transform their work entirely. Today, DJI serves to build a better world by continuously promoting human advancement. With a solution-oriented mindset and genuine curiosity, DJI has expanded its ambitions into areas such as renewable energy, agriculture, public safety, surveying and mapping, and infrastructure inspection. In every application, DJI products deliver experiences that add value to lives around the world in more profound ways than ever before.

For more information, visit our:

Website: https://enterprise.dji.com  
Facebook: www.facebook.com/DJIEnterpriseOfficial/       
X: https://X.com/DJIEnterprise   
LinkedIn: www.linkedin.com/company/dji    
Subscribe to our YouTube Channel: www.youtube.com/@DJIEnterprise   

About TOPR:

TOPR (Tatrzańskie Ochotnicze Pogotowie Ratunkowe) is the dedicated volunteer mountain search and rescue organization operating in the Tatra Mountains, headquartered in Zakopane, Poland.

(Note: The accompanying multimedia case study was co-produced by DJI Enterprise and INNPRO.)

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/automated-drone-technology-further-transforms-polish-mountain-rescue-operations-302927891.html

Continue Reading

Technology

SlidesAI Expands Beyond Google Slides With Standalone AI Presentation Platform

Published

on

By

Users can now create, edit and share presentations directly in their browser, alongside integrations with Google Slides, Microsoft PowerPoint and ChatGPT.

SHARJAH, UAE, Nov. 3, 2026 /PRNewswire/ — SlidesAI, an AI presentation maker that began as a Google Slides add-on, has expanded into a standalone presentation platform with its own browser-based workspace.

First released earlier this year, the SlidesAI web app lets users turn ideas, notes and documents into presentations without installing an add-on or working inside Google Slides or PowerPoint. It brings presentation planning, content creation, design and editing into one workspace.

“We started as a Google Slides add-on, then a PowerPoint add-in, and that’s where we found our first users and grew to over twelve million,” said Anurag Bhagsain, founder of SlidesAI. “But honestly, the product outgrew that framing.”

The standalone platform extends SlidesAI’s role across the presentation process. Users begin with a topic, notes or a document, then specify their audience, tone, language and slide count. Before generating the deck, they can review the outline, reorder slides and refine the content. Once the presentation opens in the editor, they can edit text directly or request AI revisions, review the suggested changes and accept them.

The need for help across those steps is reflected in a recent SlidesAI onboarding survey. Among more than 18,000 responding new users, roughly two-thirds selected design and visuals as a presentation challenge, while nearly half selected the time required. Respondents could select multiple challenges.

Those responses illustrate why generating slide text addresses only part of the work. Turning that content into a structured, visually coherent presentation also requires decisions about sequence, layout and design. SlidesAI’s web-based AI presentation maker lets users work through those stages within the same environment.

For organizations creating recurring presentations, Brand Kit lets users import an existing PowerPoint template and apply their colors, fonts, logos and layouts to generated decks. Finished presentations can be presented directly, shared through a link or exported to PowerPoint or Google Slides.

SlidesAI also continues to support its existing integrations. Users can create and refine presentations through the PowerPoint add-in, work directly within Google Slides, or use ChatGPT to generate presentations directly in their SlidesAI account.

About SlidesAI

SlidesAI is an AI presentation creation and editing platform for professionals, educators and students. Available as a standalone web app and through integrations with Google Slides, Microsoft PowerPoint and ChatGPT, SlidesAI helps users turn ideas and source material into editable presentations. Learn more at  https://www.slidesai.io/.

Media contact
Anurag Bhagsain
+917018743674
426118@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/slidesai-expands-beyond-google-slides-with-standalone-ai-presentation-platform-302926828.html

SOURCE SlidesAI

Continue Reading

Technology

RepData Launches Verified Intelligence Platform, Establishing New Category for End-to-End Research

Published

on

By

Quality-led market research platform combines survey creation, participant sourcing, data quality verification, analysis and AI-powered automation in a closed-loop system 

NEW ORLEANS, Nov. 3, 2026 /PRNewswire/ — Rep Data has launched the Verified Intelligence Platform (VIP), an end-to-end research and insights solution that takes teams from business questions to actionable insights, with data quality verified throughout. The platform allows researchers to design studies, source verified respondents, detect fraud and low-quality responses, and analyze results in one connected system, with the flexibility to manage research themselves or work with Rep Data’s experts.

The platform builds on RepData’s sample sourcing and fraud prevention technology, adding survey design, behavioral data quality assessment and advanced analytics through its recent acquisitions of ReDem, OWL and SightX. It incorporates RepData’s curated participant network and quality checks at the source, respondent and response levels. The launch establishes Verified Intelligence as a new category of research with data quality verified at every step and visible to customers.

“Insights teams shouldn’t have to make high-stakes decisions on questionable data or choose between quality and speed,” said Patrick Stokes, CEO and Founder of RepData. “We’ve built the only research platform that offers this level of capability, technology and transparency in one place. Quality has been part of our DNA since day one, and VIP sets a new standard for conducting research and making decisions with confidence.”

Verification is integrated throughout the platform, with customers able to see how data quality is assessed at each stage:

Source: The next generation of Research Defender scores sample sources and blocks low-quality sources in real time, including during and after fieldwork.Respondent: More than 120 signals are analyzed and scored together for each respondent, identifying fraud, inattention and AI text responses before and during surveys.Response: Every response receives a score from 0 to 100 across five criteria (open-ended responses, behavioral analytics, time, grid and coherence), with plain-language explanations of flagged responses.Replacement: Rejected respondents are automatically replaced during fieldwork, eliminating need for data cleaning after the fact and shortening research timelines.Learning: Results from each study are used to retrain quality models, improving detection over time.

RepData’s VIP supports and embeds agentic research workflows, where AI agents can create surveys, launch studies, collect results, analyze data and prepare reports, with verification throughout.

Customers can use RepData’s technology and services in three ways:

Integrated platform: The Verified Intelligence Platform includes more than 50 research methodologies and question types, a panel network spanning 50 countries, pre-survey quality checks, automated data cleaning, analysis, reporting and actionable recommendations.Individual products: RepData’s sample marketplace and data quality tools are available through API and MCP connections for use with existing survey platforms.Research services: RepData’s research team manages projects from scoping and study design through field management, analysis and reporting.

Enterprise and mid-market teams can conduct research in-house or outsource projects, while research agencies and technology platforms can integrate RepData’s capabilities into existing systems.

The launch introduces RepData’s new brand identity and website, reflecting its expanded capabilities.

About RepData
RepData helps businesses make high-stakes decisions with confidence through verified research, advanced technology and human expertise. Its Verified Intelligence Platform (VIP) provides an end-to-end solution for designing, conducting and analyzing research, with data quality verification integrated at every step of the process. RepData works with enterprise and mid-market businesses, research agencies and technology platforms, offering flexible options for teams conducting research across a range of business functions, including self-service research, individual technology solutions and fully managed research services. www.repdata.com

Contact: Michelle Andre, 426176@email4pr.com, +1-415-577-8634

View original content to download multimedia:https://www.prnewswire.com/news-releases/repdata-launches-verified-intelligence-platform-establishing-new-category-for-end-to-end-research-302927802.html

SOURCE Rep Data

Continue Reading

Trending